Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is completed. It is testing Licarbazepine 750-2000 mg/d for manic episodes in bipolarity type I.
Location not clearly listedThis study is completed in the United States. It is testing licarbazepine for manic episodes in bipolarity type I.
In CerritosThis study is enrolling by invitation in the United States, in Bulgaria, in Czechia, .... It is testing SPT-300 (GlyphAllo) for depression.
Multiple locations, including Chino
This study is completed in France. It is testing pimavanserin for Schizophrenia.
In FranceThis study is completed in the United States. It focuses on schizophrenia.
In CatonsvilleThis study is completed in the United Kingdom, in Belgium, in Germany, .... It is testing intranasal Esketamine for treatment-resistant depression.
In GermanyThis study is completed in the United Kingdom, in Sweden, in Denmark, .... It focuses on Addiction.
In United KingdomThis study is completed in the United States. It is testing sublocade for Addiction.
In New YorkThis study is completed in the United States. It is testing Open-Label Pilot Trial of Alpha Lipoic Acid (ALA) for Weight Loss for schizophrenia.
In New HavenThis study is completed in France, in Belgium, in Lithuania, .... It focuses on schizophrenia.
In LithuaniaThis study is completed in Italy. It is testing bifeprunox investigating flexible doses of 20, 30, or 40mg/day for schizophrenia.
In ItalyThis study is completed in the United States. It is testing pimavanserin for Schizophrenia.
In DanburyHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.